(VIANEWS) – American Public Education (APEI), Astrazeneca (AZN), Exelixis (EXEL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. American Public Education (APEI)

76.3% sales growth and 7.15% return on equity

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education.

American Public Education’s sales growth this year is anticipated to be 25.2% and 56.7% for next year.

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 335.71M for the twelve trailing months.

American Public Education’s sales growth is a negative 0% for the current quarter and 76.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 94.4% and negative -17%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.15%.

Volatility

American Public Education’s last day, last week, and last month’s current intraday variation average was 0.90%, 2.63%, and 2.19%, respectively.

American Public Education’s highest amplitude of average volatility was 6.69% (day), 4.05% (last week), and 3.91% (last month), respectively.

American Public Education’s Stock Yearly Top and Bottom Value

American Public Education’s stock is valued at $23.26 at 19:23 EST, way below its 52-week high of $39.19 and way higher than its 52-week low of $18.11.

American Public Education’s Moving Average

American Public Education’s value is under its 50-day moving average of $24.12 and way below its 200-day moving average of $28.12.

2. Astrazeneca (AZN)

43% sales growth and 25.67% return on equity

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.

Astrazeneca’s sales growth this year is anticipated to be 35.1% and 15.7% for next year.

Year-on-year quarterly revenue growth grew by 31%, now sitting on 29.53B for the twelve trailing months.

Volume

Today’s last reported volume for Astrazeneca is 4782310 which is 6.72% above its average volume of 4480830.

Astrazeneca’s sales growth for the next quarter is 43%. The company’s growth estimates for the ongoing quarter and the next is 40.4% and 45.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.67%.

Volatility

Astrazeneca’s last day, last week, and last month’s current intraday variation average was 0.69%, 0.62%, and 1.69%, respectively.

Astrazeneca’s highest amplitude of average volatility was 1.55% (day), 1.12% (last week), and 1.29% (last month), respectively.

Astrazeneca’s Stock Yearly Top and Bottom Value

Astrazeneca’s stock is valued at $56.88 at 19:23 EST, way under its 52-week high of $64.21 and way higher than its 52-week low of $46.48.

Astrazeneca’s Moving Average

Astrazeneca’s value is under its 50-day moving average of $61.00 and under its 200-day moving average of $58.24.

3. Exelixis (EXEL)

38.8% sales growth and 4.85% return on equity

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States.

Exelixis’s sales growth this year is expected to be 39.3% and 16.6% for next year.

Year-on-year quarterly revenue growth grew by 48.4%, now sitting on 1.16B for the twelve trailing months.

Volume

Today’s last reported volume for Exelixis is 1891150 which is 3.43% above its average volume of 1828340.

Exelixis’s sales growth for the next quarter is 38.8%. The company’s growth estimates for the present quarter and the next is 240% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.85%.

Volatility

Exelixis’s last day, last week, and last month’s current intraday variation average was 2.64%, 2.45%, and 2.06%, respectively.

Exelixis’s highest amplitude of average volatility was 4.56% (day), 3.98% (last week), and 3.62% (last month), respectively.

Exelixis’s Stock Yearly Top and Bottom Value

Exelixis’s stock is valued at $18.68 at 19:23 EST, way below its 52-week high of $25.77 and way higher than its 52-week low of $15.50.

Exelixis’s Moving Average

Exelixis’s value is below its 50-day moving average of $18.98 and under its 200-day moving average of $20.61.

4. FIRST REPUBLIC BANK (FRC)

21.6% sales growth and 10.5% return on equity

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, real estate lending, and wealth management services to clients in metropolitan areas in the United States.

FIRST REPUBLIC BANK’s sales growth this year is expected to be 26.2% and 14.5% for next year.

Year-on-year quarterly revenue growth grew by 30.4%, now sitting on 4.68B for the twelve trailing months.

FIRST REPUBLIC BANK’s sales growth for the next quarter is 21.6%. The company’s growth estimates for the ongoing quarter and the next is 14.9% and 16.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.5%.

Volatility

FIRST REPUBLIC BANK’s last day, last week, and last month’s current intraday variation average was 2.67%, 3.85%, and 1.27%, respectively.

FIRST REPUBLIC BANK’s highest amplitude of average volatility was 3.65% (day), 5.51% (last week), and 2.37% (last month), respectively.

FIRST REPUBLIC BANK’s Stock Yearly Top and Bottom Value

FIRST REPUBLIC BANK’s stock is valued at $197.97 at 19:23 EST, way below its 52-week high of $222.86 and way higher than its 52-week low of $129.20.

FIRST REPUBLIC BANK’s Moving Average

FIRST REPUBLIC BANK’s value is below its 50-day moving average of $213.27 and above its 200-day moving average of $194.12.

5. LightInTheBox Holding Co., Ltd. (LITB)

19.8% sales growth and 34.14% return on equity

LightInTheBox Holding Co., Ltd., together with its consolidated subsidiaries, engages in the online retailing of various products and services to consumers worldwide.

LightInTheBox Holding Co., Ltd.’s sales growth this year is expected to be 9.4% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 117.5%, now sitting on 458.68M for the twelve trailing months.

Volume

Today’s last reported volume for LightInTheBox Holding Co., Ltd. is 120756 which is 62.01% below its average volume of 317925.

LightInTheBox Holding Co., Ltd.’s sales growth for the next quarter is 19.8%. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.14%.

Volatility

LightInTheBox Holding Co., Ltd.’s last day, last week, and last month’s current intraday variation average was 2.97%, 7.13%, and 5.18%, respectively.

LightInTheBox Holding Co., Ltd.’s highest amplitude of average volatility was 9.18% (day), 11.49% (last week), and 9.99% (last month), respectively.

LightInTheBox Holding Co., Ltd.’s Stock Yearly Top and Bottom Value

LightInTheBox Holding Co., Ltd.’s stock is valued at $1.07 at 19:23 EST, way under its 52-week high of $5.69 and way higher than its 52-week low of $0.87.

LightInTheBox Holding Co., Ltd.’s Moving Average

LightInTheBox Holding Co., Ltd.’s worth is way below its 50-day moving average of $1.37 and way below its 200-day moving average of $1.88.

6. Quanta Services (PWR)

11.4% sales growth and 12.27% return on equity

Quanta Services, Inc. provides specialty contracting services in the United States, Canada, Australia, Latin America, and internationally.

Quanta Services’s sales growth this year is expected to be 10.5% and 12.6% for next year.

Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 11.14B for the twelve trailing months.

Volume

Today’s last reported volume for Quanta Services is 156603 which is 84.49% below its average volume of 1009980.

Quanta Services’s sales growth for the next quarter is 11.4%. The company’s growth estimates for the ongoing quarter and the next is 3.6% and 1.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.27%.

Volatility

Quanta Services’s last day, last week, and last month’s current intraday variation average was 1.62%, 1.05%, and 1.39%, respectively.

Quanta Services’s highest amplitude of average volatility was 2.15% (day), 1.84% (last week), and 2.62% (last month), respectively.

Quanta Services’s Stock Yearly Top and Bottom Value

Quanta Services’s stock is valued at $112.91 at 19:23 EST, under its 52-week high of $124.69 and way above its 52-week low of $67.60.

Quanta Services’s Moving Average

Quanta Services’s value is below its 50-day moving average of $116.04 and way above its 200-day moving average of $102.40.

LEAVE A REPLY

Please enter your comment!
Please enter your name here